SPDR S&P Biotech ETF Rating → Claim Your Complimentary Bitcoin Reward (From Crypto Swap Profits) (Ad) Free XBI Stock Alerts $85.85 +2.36 (+2.83%) (As of 02:15 PM ET) Add Compare Share Share RatingsStock AnalysisChartHeadlinesHoldingsOwnershipRatingsStock AnalysisChartHeadlinesHoldingsOwnershipRatings SPDR S&P Biotech ETF Aggregate Rating and Price Target (2024)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.XBI Aggregate RatingModerate Buy2.77Holdings in XBI have an aggregate rating of Moderate Buy based on 593 analyst ratings issued in the past year covering 50 companies (52.7% of the portfolio).XBI Aggregate Price Target$122.8342.70% UpsideHigh Prediction$169.43Average Prediction$122.83Low Prediction$81.85Holdings in XBI have an aggregate price target of $122.83 and a range of $81.85 to $169.43 covering 50 companies (52.7% of the portfolio).XBI Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy17 Buy rating(s)Moderate Buy26 Moderate Buy rating(s)Hold6 Hold rating(s)Reduce1 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by SPDR S&P Biotech ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 50 XBI Holdings Export to ExcelWeightIn ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings1.80%ALPNAlpine Immune Sciences$64.66+0.2%2 of 5 stars2.27$50.33 -22.2%11Short Interest ↓Positive News1.30%EXASExact Sciences$59.08+0.4%4 of 5 stars2.86$97.44 64.9%14Short Interest ↑Positive News1.22%RVMDRevolution Medicines$36.76+2.2%4 of 5 stars3.10$41.20 12.1%10Positive News1.19%CYTKCytokinetics$63.42-2.9%4 of 5 stars2.87$79.33 25.1%15Short Interest ↑1.17%BMRNBioMarin Pharmaceutical$83.27+2.9%5 of 5 stars2.63$107.50 29.1%19Analyst ReportShort Interest ↑Analyst Revision1.16%NTRANatera$94.37+3.0%2 of 5 stars3.00$86.40 -8.4%141.15%CRNXCrinetics Pharmaceuticals$44.38+5.4%4 of 5 stars2.91$54.00 21.7%11Upcoming EarningsShort Interest ↑1.12%ROIVRoivant Sciences$11.18+1.4%4 of 5 stars2.90$16.90 51.2%10Short Interest ↑1.12%EXELExelixis$23.81+0.5%5 of 5 stars2.60$26.29 10.4%15Upcoming EarningsShort Interest ↑Analyst Revision1.11%CERECerevel Therapeutics$42.80+0.8%0 of 5 stars2.20$41.40 -3.3%10Upcoming EarningsShort Interest ↓1.11%MRNAModerna$111.40+3.2%4 of 5 stars2.25$126.49 13.5%16Upcoming EarningsInsider Selling1.10%KRYSKrystal Biotech$159.19+1.5%4 of 5 stars3.00$171.00 7.4%9Upcoming Earnings1.08%SRPTSarepta Therapeutics$129.63+0.7%4 of 5 stars2.79$156.60 20.8%14Upcoming Earnings1.08%ALNYAlnylam Pharmaceuticals$147.71+3.1%5 of 5 stars2.59$215.88 46.1%17Upcoming EarningsAnalyst UpgradeShort Interest ↓1.07%INSMInsmed$25.20+1.6%4 of 5 stars3.00$44.92 78.2%12Upcoming EarningsPositive News1.07%AMGNAmgen$276.08+2.3%5 of 5 stars2.53$297.40 7.7%19Upcoming Earnings1.06%DYNDyne Therapeutics$25.60+3.5%4 of 5 stars3.14$37.43 46.2%7Short Interest ↑1.06%NBIXNeurocrine Biosciences$138.81+2.1%5 of 5 stars2.74$142.38 2.6%23Upcoming EarningsShort Interest ↓1.05%RYTMRhythm Pharmaceuticals$38.57+0.8%2 of 5 stars3.00$47.20 22.4%5Analyst Report1.05%VRTXVertex Pharmaceuticals$396.44-0.3%4 of 5 stars2.48$429.45 8.3%23Upcoming Earnings1.04%UTHRUnited Therapeutics$240.38+2.8%5 of 5 stars2.89$294.25 22.4%9Upcoming Earnings1.04%VKTXViking Therapeutics$74.300.0%5 of 5 stars3.00$112.25 51.1%10Earnings ReportAnalyst Revision1.04%IONSIonis Pharmaceuticals$42.08+1.2%4 of 5 stars2.69$56.08 33.3%13Positive News1.04%GERNGeron$4.23+11.6%3 of 5 stars3.00$5.33 26.1%4Upcoming EarningsAnalyst ReportShort Interest ↑Gap Up1.03%BPMCBlueprint Medicines$94.18+1.3%1 of 5 stars2.50$91.57 -2.8%14Upcoming EarningsAnalyst ReportNews Coverage1.02%REGNRegeneron Pharmaceuticals$894.15+1.2%4 of 5 stars2.70$977.77 9.4%20Upcoming Earnings1.01%RAREUltragenyx Pharmaceutical$44.49+0.6%4 of 5 stars2.92$88.08 98.0%12Upcoming Earnings1.01%MDGLMadrigal Pharmaceuticals$199.24+3.1%5 of 5 stars2.73$356.73 79.0%111.01%IMVTImmunovant$27.14-0.1%3 of 5 stars3.00$48.00 76.9%17Insider SellingShort Interest ↓Analyst RevisionNews Coverage1.01%IDYAIDEAYA Biosciences$40.61+1.7%3 of 5 stars3.00$46.60 14.8%121.01%HALOHalozyme Therapeutics$39.04+1.2%5 of 5 stars2.86$53.29 36.5%71.01%BBIOBridgeBio Pharma$25.39+2.0%4 of 5 stars2.80$47.82 88.3%10Upcoming EarningsShort Interest ↑1.00%VERAVera Therapeutics$41.26+4.1%0 of 5 stars3.00$32.29 -21.8%81.00%BHVNBiohaven$39.50+1.4%4 of 5 stars3.00$52.13 32.0%8Analyst Revision1.00%ARQTArcutis Biotherapeutics$8.69+2.6%2 of 5 stars2.75$26.56 205.6%8Options Volume0.99%GILDGilead Sciences$66.23+1.2%5 of 5 stars2.35$83.60 26.2%17Earnings ReportDividend AnnouncementAnalyst ReportOptions VolumeAnalyst Revision0.99%ABBVAbbVie$160.13+0.3%5 of 5 stars2.77$176.08 10.0%13Earnings ReportAnalyst Report0.98%VCELVericel$46.78+1.6%0 of 5 stars3.00$46.40 -0.8%6Positive News0.98%INCYIncyte$53.16+2.9%5 of 5 stars2.44$75.50 42.0%16Upcoming Earnings0.98%DVAXDynavax Technologies$11.36+1.3%4 of 5 stars2.75$25.00 120.1%4Analyst Downgrade0.97%BIIBBiogen$215.09+3.0%5 of 5 stars2.67$293.88 36.6%27Earnings ReportAnalyst ReportShort Interest ↓Analyst Revision0.96%SNDXSyndax Pharmaceuticals$21.14+0.4%4 of 5 stars2.90$34.42 62.8%10Analyst ReportNews Coverage0.95%RCKTRocket Pharmaceuticals$21.82-0.7%4 of 5 stars2.89$52.13 138.9%9Upcoming Earnings0.95%FOLDAmicus Therapeutics$10.38+1.0%4 of 5 stars3.00$20.00 92.7%3Positive News0.95%IRWDIronwood Pharmaceuticals$7.83+0.1%4 of 5 stars3.00$19.80 152.9%5Upcoming Earnings0.94%DNLIDenali Therapeutics$15.64+1.4%4 of 5 stars3.00$41.22 163.6%80.93%PTCTPTC Therapeutics$31.46+10.1%3 of 5 stars1.85$33.53 6.6%13Earnings ReportAnalyst UpgradeGap Up0.93%PCVXVaxcyte$61.99+2.1%2 of 5 stars3.00$78.50 26.6%40.92%TGTXTG Therapeutics$13.27-1.5%4 of 5 stars2.83$29.00 118.5%6Upcoming Earnings0.92%APLSApellis Pharmaceuticals$48.02-3.7%5 of 5 stars2.87$77.93 62.3%15Analyst Report This page (NYSEARCA:XBI) was last updated on 4/29/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe #1 Biotech Stock to Have on Your Radar in 2024… Huge AlertsAI finds its first serious applicationWall Street StarHave You Seen Elon’s New A.I. Device? (Picture Inside)InvestorPlaceHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportDid You Get Your Free Bitcoin Yet?Crypto Swap Profits4 coins to be the “Next Bitcoin”True Market InsidersRich Dad Poor Dad Author Shocks Millions With 2024 Crash WarningAmerican Hartford Gold Group Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding SPDR S&P Biotech ETF Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
